1
Han Cheng Zhang, Bruce E Maryanoff, Hong Ye, Bruce R Conway, Keith Demarest: Substituted pyrrolines as kinase inhibitors. Janssen Pharmaceutica, Gabriel Lopez, Hal B Woodrow, January 17, 2006: US06987110 (44 worldwide citation)

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


2
Han Cheng Zhang, Bruce E Maryanoff, David F McComsey, Kimberly White, Hong Ye, Leonard R Hecker, Bruce Conway, Keith Demarest: Substituted pyrrolines as kinase inhibitors. Janssen Pharmaceutica, June 19, 2007: US07232906 (5 worldwide citation)

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


3
Han Cheng Zhang, Bruce E Maryanoff, David F McComsey, Kimberly White, Hong Ye, Leonard R Hecker, Bruce Conway, Keith Demarest: Substituted pyrrolines as kinase inhibitors. Janssen Pharmaceutica, Yuny P Stercho, October 27, 2009: US07608634

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


4
Han Cheng Zhang, Bruce E Maryanoff, David F McComsey, Kimberly White, Hong Ye, Leonard R Hecker: Substituted pyrrolines as kinase inhibitors. Janssen Pharmaceutica, Yurity P Stercho, July 20, 2010: US07759380

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


5
Zhang Han Cheng, Maryanoff Bruce E, Mccomsey David F, White Kimberly, Ye Hong, Hecker Leonard, Conway Bruce R, Demarest Keith: Substituted pyrrolines as kinase inhibitors. Janssen Pharmaceutica, March 16, 2005: EP1513520-A2

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


6
Han Cheng Zhang, Bruce E Maryanoff, Hong Ye, Bruce R Conway, Keith Demarest: Substituted pyrrolines as kinase inhibitors. Philip S Johnson, Johnson & Johnson, March 25, 2004: US20040059113-A1

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


7
Han Cheng Zhang, Bruce E Maryanoff, David F McComsey, Kimberly White, Hong Ye, Leonard R Hecker, Bruce Conway, Keith Demarest: Substituted pyrrolines as kinase inhibitors. Philip S Johnson, Johnson & Johnson, September 13, 2007: US20070213386-A1

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


8
Han Cheng Zhang, Bruce E Maryanoff, David F McComsey, Kimberly White, Hong Ye, Leonard R Hecker, Bruce Conway, Keith Demarest: Substituted pyrrolines as kinase inhibitors. Philip S Johnson, Johnson & Johnson, September 13, 2007: US20070213387-A1

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


9
Han Cheng Zhang, Bruce E Maryanoff, David F McComsey, Kimberly White, Hong Ye, Leonard R Hecker, Bruce Conway, Keith Demarest: Substituted pyrrolines as kinase inhibitors. Philip S Johnson, Johnson & Johnson, March 18, 2004: US20040054180-A1

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.


10
Han Cheng Zhang, Bruce E Maryanoff, David F McComsey, Kimberly White, Hong Ye, Leonard R Hecker, Bruce Conway, Keith Demarest: Substituted pyrrolines as kinase inhibitors. Philip S Johnson, Johnson & Johnson, September 23, 2010: US20100240650-A1

The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.